21 results
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
package he had while serving as President of Maravai’s Biologics Safety Testing segment. Mr. Martin ceased serving as President of Maravai’s Biologics
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
compensation package, as previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission
10-Q
vfmxv e11o0hp7gd8wr
12 May 21
Quarterly report
4:26pm
424B4
10qvmbzi9x7tkhq2jd65
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
tnuuiefril
25 Mar 21
Draft registration statement
12:00am
10-K
v9rw74i7ax
22 Mar 21
Annual report
4:22pm
424B4
e0a1q7w3tyjs
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
EX-10.15
tve49y
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.17
yk7k 7ehdabk321n1irf
29 Oct 20
IPO registration
5:04pm
S-1
06itk
29 Oct 20
IPO registration
5:04pm
DRS/A
4myq7a f4lvi8w
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.15
b946ei fg6joydw09
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
upmor
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
8p0bus
14 Oct 20
Draft registration statement (amended)
12:00am